Team: Bios

Ansbert K. Gadicke, MD Managing Director

Dr. Ansbert Gadicke is the founder of the MPM Group and in 1997 co-founded its asset management business. He led MPM's effort to build its Advisory and Investment Banking business from 1992 to 1996. Prior to founding MPM, Dr. Gadicke was employed by The Boston Consulting Group. Dr. Gadicke received an M.D. from J.W. Goethe University in Frankfurt. He subsequently held research positions in biochemistry and molecular biology at the Whitehead Institute at MIT and Harvard University. At the German Cancer Research Center, Dr. Gadicke cloned the first cDNAs of HPV16 and 18 in Prof. Harald zur Hausen's group (Nobel Laureate in Physiology or Medicine, 2008). Dr. Gadicke has published in leading scientific publications including Nature and Cell. He is a member of the Harvard Medical School Board of Fellows.

Present Boards
Dragonfly Sciences, Inc.
Radius Health, Inc.
Solasia Pharma K.K.
Verastem, Inc.

Past Boards
BioMarin Pharmaceuticals, Inc. (NASDAQ:BMRN)
Biovitrum AB (Stockholm:BVT)
Chiasma, Inc.
Coelacanth Corp.
Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX)
Kourion Therapeutics AG
MediGene AG (Frankfurt:MDG)
National Venture Capital Association
Omrix Biopharmaceuticals, Inc. (NASDAQ:OMRI)
Pharmasset, Inc. (NASDAQ:VRUS)
PharmAthene, Inc. (ASE:PIP)
TransForm Pharmaceuticals, Inc.
ViaCell, Inc. (NASDAQ:VIAC)